SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ATIS is on the move!
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
2205 22 0 ATIS
Emcee:  Rick Costantino Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
55 Rick, No news today, but some brief observations. Still relatively light Marshall Teitelbaum-8/26/1996
54 Rick, I agree with your thoughts about the way ATIS is positioning itself, Marshall Teitelbaum-8/24/1996
53 I work in the bioecth industry in pharmaceutical R & D (at Genentech in SouRick Costantino-8/24/1996
52 Rick, Now there's the tough part....waiting and watching patiently. Marshall Teitelbaum-8/23/1996
51 Marshall, thanks again for your very thoughtful reply. I appreciate your time Rick Costantino-8/23/1996
50 Rick, I'm not sure you really need my advice considering I'm not eMarshall Teitelbaum-8/23/1996
49 Bill, Slight rebound for ATIS today, making it up to 13 briefly before dropMarshall Teitelbaum-8/23/1996
48 Thanks for your advice. Your are right in that biotechs truly are long-term piRick Costantino-8/23/1996
47 Marshall, I'll review MNMD, and thanks for the lead. As you, I'm impreWWS-8/23/1996
46 Bill, Not at the moment. Their primary advantage now is the particular arMarshall Teitelbaum-8/23/1996
45 Marshall, RZYM appears to be a "junior" in the world of biotechs: plWWS-8/22/1996
44 Rick, No news for ATIS, as well as no news for GENZ(although has been for Marshall Teitelbaum-8/22/1996
43 ATIS is on the move - down today. Any news at all?...I'm concerned especiaRick Costantino-8/22/1996
42 Marshall, just in case you missed the last (and most comprehensive) post on IMMWWS-8/21/1996
41 Bill, Just briefly reviewed some info on Immunomedics...looks quite interesMarshall Teitelbaum-8/21/1996
40 Rick, There had been 2 studies underway for dermagraft, with the French stMarshall Teitelbaum-8/21/1996
39 Thanks for a very informative post. What did you mean about "questions abRick Costantino-8/21/1996
38 Rick, I spoke with ATIS today(Marie). She, as per last time we spoke a feMarshall Teitelbaum-8/21/1996
37 Rick, Your best case scenario from #35 appears fairly accurate. ObviouslMarshall Teitelbaum-8/19/1996
36 You are discussing an intersting point. The "off label" use of many Rick Costantino-8/19/1996
35 Marshall, Thanks for the info. Wow, a $1 billion market for diabetic foot ulceRick Costantino-8/19/1996
34 Cliff, I did read (several months ago) how ATIS was gearing up for large-scale Rick Costantino-8/19/1996
33 Bill, One key to remember is that companies are not allowed to tout any iMarshall Teitelbaum-8/18/1996
32 Marshall, thanks for discussing "indications" in the context of proceWWS-8/18/1996
31 Bill, I sure hope there is room for even more than two, because companies lMarshall Teitelbaum-8/17/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News